Literature DB >> 30643249

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Zhaohui Gu1, Michelle L Churchman1, Kathryn G Roberts1, Ian Moore1, Xin Zhou2, Joy Nakitandwe1, Kohei Hagiwara2, Stephane Pelletier3, Sebastien Gingras4, Hartmut Berns5, Debbie Payne-Turner1, Ashley Hill1, Ilaria Iacobucci1, Lei Shi6, Stanley Pounds6, Cheng Cheng6, Deqing Pei6, Chunxu Qu1, Scott Newman2, Meenakshi Devidas7, Yunfeng Dai7, Shalini C Reshmi8, Julie Gastier-Foster8, Elizabeth A Raetz9, Michael J Borowitz10, Brent L Wood11, William L Carroll12, Patrick A Zweidler-McKay13, Karen R Rabin14, Leonard A Mattano15, Kelly W Maloney16, Alessandro Rambaldi17, Orietta Spinelli17, Jerald P Radich18, Mark D Minden19, Jacob M Rowe20, Selina Luger21, Mark R Litzow22, Martin S Tallman23, Janis Racevskis24, Yanming Zhang25, Ravi Bhatia26, Jessica Kohlschmidt27, Krzysztof Mrózek27, Clara D Bloomfield27, Wendy Stock28, Steven Kornblau29, Hagop M Kantarjian29, Marina Konopleva29, Williams E Evans30, Sima Jeha31, Ching-Hon Pui31, Jun Yang30, Elisabeth Paietta24, James R Downing1, Mary V Relling30, Jinghui Zhang2, Mignon L Loh32, Stephen P Hunger33, Charles G Mullighan34.   

Abstract

Recent genomic studies have identified chromosomal rearrangements defining new subtypes of B-progenitor acute lymphoblastic leukemia (B-ALL), however many cases lack a known initiating genetic alteration. Using integrated genomic analysis of 1,988 childhood and adult cases, we describe a revised taxonomy of B-ALL incorporating 23 subtypes defined by chromosomal rearrangements, sequence mutations or heterogeneous genomic alterations, many of which show marked variation in prevalence according to age. Two subtypes have frequent alterations of the B lymphoid transcription-factor gene PAX5. One, PAX5alt (7.4%), has diverse PAX5 alterations (rearrangements, intragenic amplifications or mutations); a second subtype is defined by PAX5 p.Pro80Arg and biallelic PAX5 alterations. We show that p.Pro80Arg impairs B lymphoid development and promotes the development of B-ALL with biallelic Pax5 alteration in vivo. These results demonstrate the utility of transcriptome sequencing to classify B-ALL and reinforce the central role of PAX5 as a checkpoint in B lymphoid maturation and leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30643249      PMCID: PMC6525306          DOI: 10.1038/s41588-018-0315-5

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  63 in total

Review 1.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function.

Authors:  Alexandra Schebesta; Shane McManus; Giorgia Salvagiotto; Alessio Delogu; Georg A Busslinger; Meinrad Busslinger
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Diagnosis of multiple cancer types by shrunken centroids of gene expression.

Authors:  Robert Tibshirani; Trevor Hastie; Balasubramanian Narasimhan; Gilbert Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

5.  A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex.

Authors:  Shannon M Lauberth; Michael Rauchman
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

6.  Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.

Authors:  Hagop Kantarjian; Deborah Thomas; Susan O'Brien; Jorge Cortes; Francis Giles; Sima Jeha; Carlos E Bueso-Ramos; Sherry Pierce; Jianqin Shan; Charles Koller; Miloslav Beran; Michael Keating; Emil J Freireich
Journal:  Cancer       Date:  2004-12-15       Impact factor: 6.860

7.  Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

Authors:  Deborah A Thomas; Stefan Faderl; Jorge Cortes; Susan O'Brien; Francis J Giles; Steven M Kornblau; Guillermo Garcia-Manero; Michael J Keating; Michael Andreeff; Sima Jeha; Miloslav Beran; Srdan Verstovsek; Sherry Pierce; Laurie Letvak; August Salvado; Richard Champlin; Moshe Talpaz; Hagop Kantarjian
Journal:  Blood       Date:  2003-10-09       Impact factor: 22.113

8.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis.

Authors:  B Adams; P Dörfler; A Aguzzi; Z Kozmik; P Urbánek; I Maurer-Fogy; M Busslinger
Journal:  Genes Dev       Date:  1992-09       Impact factor: 11.361

9.  High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

Authors:  R P Kuiper; E F P M Schoenmakers; S V van Reijmersdal; J Y Hehir-Kwa; A Geurts van Kessel; F N van Leeuwen; P M Hoogerbrugge
Journal:  Leukemia       Date:  2007-04-19       Impact factor: 11.528

10.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

View more
  138 in total

Review 1.  Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.

Authors:  Jianfeng Li; Yuting Dai; Liang Wu; Ming Zhang; Wen Ouyang; Jinyan Huang; Saijuan Chen
Journal:  Front Med       Date:  2021-01-05       Impact factor: 4.592

Review 2.  How advanced are we in targeting novel subtypes of ALL?

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2019-10-18       Impact factor: 3.020

3.  Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.

Authors:  Pablo Iglesias; Ann-Christin Puller; Marcos Seoane; Michael Spohn; Sabine Raasch; Marianne Klokow; Jürgen Müller; Lia Burkhardt; Daniela Indenbirken; Martin A Horstmann
Journal:  Blood Adv       Date:  2021-03-09

Review 4.  IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?

Authors:  Martin Stanulla; Hélène Cavé; Anthony V Moorman
Journal:  Blood       Date:  2020-01-23       Impact factor: 22.113

Review 5.  Molecular markers in ALL: Clinical implications.

Authors:  Shunsuke Kimura; Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2020-06-07       Impact factor: 3.020

6.  RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.

Authors:  Filip Matthijssens; Nitesh D Sharma; Monique Nysus; Christian K Nickl; Huining Kang; Dominique R Perez; Beatrice Lintermans; Wouter Van Loocke; Juliette Roels; Sofie Peirs; Lisa Demoen; Tim Pieters; Lindy Reunes; Tim Lammens; Barbara De Moerloose; Filip Van Nieuwerburgh; Dieter L Deforce; Laurence C Cheung; Rishi S Kotecha; Martijn Dp Risseeuw; Serge Van Calenbergh; Takeshi Takarada; Yukio Yoneda; Frederik W van Delft; Richard B Lock; Seth D Merkley; Alexandre Chigaev; Larry A Sklar; Charles G Mullighan; Mignon L Loh; Stuart S Winter; Stephen P Hunger; Steven Goossens; Eliseo F Castillo; Wojciech Ornatowski; Pieter Van Vlierberghe; Ksenia Matlawska-Wasowska
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

7.  Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.

Authors:  Matthew T Witkowski; Igor Dolgalev; Nikki A Evensen; Chao Ma; Tiffany Chambers; Kathryn G Roberts; Sheetal Sreeram; Yuling Dai; Anastasia N Tikhonova; Audrey Lasry; Chunxu Qu; Deqing Pei; Cheng Cheng; Gabriel A Robbins; Joanna Pierro; Shanmugapriya Selvaraj; Valeria Mezzano; Marla Daves; Philip J Lupo; Michael E Scheurer; Cynthia A Loomis; Charles G Mullighan; Weiqiang Chen; Karen R Rabin; Aristotelis Tsirigos; William L Carroll; Iannis Aifantis
Journal:  Cancer Cell       Date:  2020-05-28       Impact factor: 31.743

8.  An intact gut microbiome protects genetically predisposed mice against leukemia.

Authors:  Carolina Vicente-Dueñas; Stefan Janssen; Marina Oldenburg; Franziska Auer; Inés González-Herrero; Ana Casado-García; Marta Isidro-Hernández; Javier Raboso-Gallego; Philipp Westhoff; Aleksandra A Pandyra; Daniel Hein; Katharina L Gössling; Diego Alonso-López; Javier De Las Rivas; Sanil Bhatia; Francisco Javier García-Criado; María Begoña García-Cenador; Andreas P M Weber; Karl Köhrer; Julia Hauer; Ute Fischer; Isidro Sánchez-García; Arndt Borkhardt
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

9.  Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.

Authors:  Hiroo Ueno; Kenichi Yoshida; Yusuke Shiozawa; Yasuhito Nannya; Yuka Iijima-Yamashita; Nobutaka Kiyokawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Tomoya Isobe; Masafumi Seki; Shunsuke Kimura; Hideki Makishima; Masahiro M Nakagawa; Nobuyuki Kakiuchi; Keisuke Kataoka; Tetsuichi Yoshizato; Dai Nishijima; Takao Deguchi; Kentaro Ohki; Atsushi Sato; Hiroyuki Takahashi; Yoshiko Hashii; Sadao Tokimasa; Junichi Hara; Yoshiyuki Kosaka; Koji Kato; Takeshi Inukai; Junko Takita; Toshihiko Imamura; Satoru Miyano; Atsushi Manabe; Keizo Horibe; Seishi Ogawa; Masashi Sanada
Journal:  Blood Adv       Date:  2020-10-27

10.  The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia.

Authors:  Lauren M Brown; Andrew Lonsdale; Andrea Zhu; Nadia M Davidson; Breon Schmidt; Anthony Hawkins; Elise Wallach; Michelle Martin; Francoise M Mechinaud; Seong Lin Khaw; Ray C Bartolo; Louise E A Ludlow; Jackie Challis; Ian Brooks; Vida Petrovic; Nicola C Venn; Rosemary Sutton; Ian J Majewski; Alicia Oshlack; Paul G Ekert
Journal:  Blood Adv       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.